Asian Journal of Chemistry; Vol. 26, No. 24 (2014), 8569-8571
ASIAN JOURNAL OF CHEMISTRY
Synthesis and Structure of bis(2,5-Dioxopyrrolidin-1-yl)adipate
1
1
2,*
JINGYU ZHANG , XUAN ZHAO and XUEHUI HOU
1
2
School of Pharmacy Henan University of Traditional Chinese Medicine, Zhengzhou 450008, P.R. China
Department of Quality Detection and Management, Henan University of Animal Husbandry and Economy, Zhengzhou 450011, P.R. China
*
Received: 20 June 2014; Accepted: 15 September 2014; Published online: 1 December 2014;
AJC-16405
bis(2,5-Dioxopyrrolidin-1-yl)adipate was prepared from adipate. Its structure was determined by single crystal X-ray diffraction analysis.
The crystals are monoclinic space group P2 /c with a = 5.2972(3), b = 7.5196(5), c = 19.2660(13) Å, α = 90.00, β = 99.776(6), γ = 90.00°,
1
3
3
-1
V = 756.28(8) Å , Z = 2, F(000) = 356.0, D = 1.494 g/cm , µ = 1.070 mm , the final R = 0.0511 and wR = 0.1135. A total of 2484
c
reflections were collected, of which 1342 were independent (Rint = 0.0255).
Keywords: Adipate derivative, Synthesis, Crystal structure.
4
INTRODUCTION
with SHELXS-97 and refined by the full-matrix least squares
5
method on F data using SHELXL-97 . The empirical absor-
2
Adipate derivative and N-hydroxy succinimide derivatives
ption corrections were applied to all intensity data. H atom of
N-H was initially located in a difference Fourier map and were
refined with the restraint Uiso(H) = 1.2 Ueq(N). Other H atoms
were positioned geometrically and refined using a riding
model, with d(C-H) = 0.93-0.97 Å and Uiso(H) = 1.2 Ueq(C)
or 1.5 Ueq(C-methyl).
Synthesis of title compound: As shown in Scheme-I, to
a solution of N-hydroxy succinimide (0.05 mol) in tetrahy-
drofuran (80 mL) was added a solution of dicyclohexyl-
carbodiimide (DCC) (0.175 mol) in tetrahydrofuran (20 mL).
The mixture was heated to 55 °C under stirring and kept for
are important structural elements in the preparation of poly-
peptide or antisense oligonucleotides (ODNs) which have a
diverse range of clinical applications in the treatmentof a variety
1
2
3
of diseases such as viral infection , tumor , vessel restenosis ,
4
5
fulminant septic shock , asthma and allergies . In our earlier
paper, we have reported the application of N-hydroxy succini-
6
mide derivative on the synthesis of antisense oligonucleotides .
To improve the function of compounds with new and attractive
characteristics, structural modifications of linker have been
extensively investigated. As a periodical result, we report
a novel linker derivative for the preparation of modified
nanogold.
1
h. Then compound 1 was added to the mixture stirring for
another 2 h at room temperature. After the compound 1
disappeared by TLC detection, the mixture was filtered and
the filtrate was evaporated under diminished pressure. The
residue was dissolved with ethyl acetate (50 mL) and washed
with saturated sodium chloride, water, orderly. Then the organic
phase was dried over anhydrous MgSO
of the dry solution gave 2 as a white ceraceous solid (76 %
yield). HRMS: Calcd for C14 340.0907; found
EXPERIMENTAL
Determination of crystal structure: The crystal of title
compound with dimensions of 0.26 mm × 0.24 mm × 0.20
mm was mounted on Xcalibur Eos Gemini diffractometer with
4
for 8 h. Evaporation
a graphite-monochromated CuK
by using a phi and scan modes at 291.15(2) K in the range of
.32º ≤ 2θ ≤ 133.96º. The crystal belongs to monoclinic system
with space group P2 /c and crystal parameters of a = 5.2972(3),
b = 7.5196(5), c = 19.2660(13) Å, α = 90.00, β = 99.776(6), γ
α
radiation (λ = 1.54184 Å)
H
16
O
8
N
2
+
9
3
41.0990 [M + H] .
1
RESULTS AND DISCUSSION
3
=
90.00°, V = 756.28(8) Å , Z = 2, F(000) = 356.0, D
c
= 1.494
g/cm . The absorption coefficient µ = 1.070 mm . The final
= 0.0404 (> 2σ(I)) and wR = 0.1028. A total of 2484
reflections were collected, of which 1342 were independent
int = 0.0255). The structure was solved by direct methods
Slow evaporation of title compound in MeOH and EtOAc
1:1) afforded colourless crystals suitable for X-ray analysis.
Structure of the title compound: The structure of title
compound 2 has been confirmed by single crystal X-ray diff-
3
-1
(
R
1
2
(R
raction analysis. Crystallographic and refinement parameters